126 related articles for article (PubMed ID: 23654205)
1. Somatic mutation of SPOP tumor suppressor gene is rare in breast, lung, liver cancers, and acute leukemias.
Kim MS; Kim MS; Yoo NJ; Lee SH
APMIS; 2014 Feb; 122(2):164-6. PubMed ID: 23654205
[No Abstract] [Full Text] [Related]
2. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
Kim MS; Jeong EG; Yoo NJ; Lee SH
Br J Cancer; 2008 May; 98(9):1533-5. PubMed ID: 18392055
[TBL] [Abstract][Full Text] [Related]
3. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
[TBL] [Abstract][Full Text] [Related]
4. Absence of paxillin gene mutation in lung cancer and other common solid cancers.
Kim MS; Yoo NJ; Lee SH
Tumori; 2011; 97(2):211-3. PubMed ID: 21617717
[TBL] [Abstract][Full Text] [Related]
5. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
[TBL] [Abstract][Full Text] [Related]
6. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
[TBL] [Abstract][Full Text] [Related]
7. Relationship between SPOP mutation and breast cancer in Chinese population.
Khan MA; Zhu L; Tania M; Xiao XL; Fu JJ
Genet Mol Res; 2015 Oct; 14(4):12362-6. PubMed ID: 26505385
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers.
Bailly M; Bain C; Favrot MC; Ozturk M
Int J Cancer; 1995 Nov; 63(5):660-4. PubMed ID: 7591282
[TBL] [Abstract][Full Text] [Related]
9. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.
Oh JE; Kim MS; Ahn CH; Kim SS; Han JY; Lee SH; Yoo NJ
Pathology; 2010 Jan; 42(1):73-6. PubMed ID: 20025484
[TBL] [Abstract][Full Text] [Related]
11. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
Zhang LN; Zha XL; Yu Q; He JY
Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.
Jeong EG; Kim MS; Nam HK; Min CK; Lee S; Chung YJ; Yoo NJ; Lee SH
Clin Cancer Res; 2008 Jun; 14(12):3716-21. PubMed ID: 18559588
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of UBR5 gene encoding an E3 ubiquitin ligase in common human cancers.
Kim MS; Oh JE; Eom HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):93-4. PubMed ID: 20025491
[No Abstract] [Full Text] [Related]
14. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 1, a newly proposed tumor suppressor gene associated with hepatocellular carcinoma.
Ohkawa K
J Gastroenterol; 2004 Jun; 39(6):598-600. PubMed ID: 15235884
[No Abstract] [Full Text] [Related]
16. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
[TBL] [Abstract][Full Text] [Related]
18. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
[TBL] [Abstract][Full Text] [Related]
19. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
Zhang J; Gao K; Xie H; Wang D; Zhang P; Wei T; Yan Y; Pan Y; Ye W; Chen H; Shi Q; Li Y; Zhao SM; Hou X; Weroha SJ; Wang Y; Zhang J; Karnes RJ; He HH; Wang L; Wang C; Huang H
Nat Commun; 2021 Sep; 12(1):5716. PubMed ID: 34588438
[TBL] [Abstract][Full Text] [Related]
20. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
